The American Diabetes Association/JDRF Type 1 Diabetes Sourcebook

Dr. Peters is involved in numerous professional organizations and activities, including the American Board of Internal Medicine (Endocrine Subspecialty Board), American College of Physicians, JDRF and the American Diabetes Association, among others. She is currently is a reviewer for Diabetes Care, JAMA and many other journals. She is a member of the ADA Publications Committee and as the Scientific Sessions Planning Committee.

Lori M. Laffel is Chief of the Pediatric, Adolescent and Young Adult Section at the Joslin Clinic, and an Investigator in the Section on Genetics and Epidemiology at the Joslin Diabetes Center (Boston), as well as an Associate Professor of Pediatrics at Harvard Medical School. She has been the Principal Investigator and Program Director of Joslin’s NIH-funded postdoctoral fellowship and early career development training grants for pediatric endocrinologists entering the field of diabetes research.

She is actively involved with the American Diabetes Association, as a member of the Boston Leadership Board, a recent past member of the National Board of Directors of the American Diabetes Association, the National Committee for Pediatric Guidelines, chair on the ADA’s Working Group on Transitions in Care for Young Adults with Diabetes, and she is chair of the ADA’s Youth Strategies Committee. She also has been a member of the Advisory Board of the International Society of Pediatric and Adolescent Diabetes. She is on the Clinical Advisory Committee for the Juvenile Diabetes Research Foundation.

Dr. Laffel received her medical degree from the University of Miami School of Medicine and her master’s degree in Public Health from the Harvard School of Public Health. She did her pediatric training at Children’s Hospital and
her fellowship training at Children’s Hospital and Joslin.

Jane L. Chiang graduated from Case Western Reserve University School of Medicine and then did a pediatrics residency at the University of California, Los Angeles. She completed a fellowship in pediatric endocrinology at the University of California at San Francisco, where she studied transcription factors involved in beta cell development.

She stayed at UCSF as a pediatric faculty member until 2005, when she joined Genentech where she played a key role in the development of novel type 1 diabetes therapeutics. She briefly joined the JDRF as Vice President of Clinical Development overseeing clinical development/medical affairs. Dr. Chiang’s experience with diabetes research and leading complex projects has helped guide this unique collaborative project.